Search research articles
Contact Us
Filters
Showing results (71-80 of 154) with videos related to
Page
of 16
Sort By:
Blood Cells, Molecules & Diseases
|
April 2, 2003
Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease
Bernard Rudensky, Esther Paz, Gheona Altarescu, et al.
American Journal of Clinical Pathology
|
June 15, 2013
Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement
Ehud Lebel, Deborah Elstein, Ariel Peleg, et al.
Journal of Osteoporosis
|
December 16, 2014
Bone mineral density in gravida: effect of pregnancies and breast-feeding in women of differing ages and parity
Ehud Lebel, Yuri Mishukov, Liana Babchenko, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
January 20, 2016
Comparison of Bone Mineral Density by Dual-Energy X-Ray Absorptiometry and Bone Strength by Speed-of-Sound Ultrasonography in Adults With Gaucher Disease
Eytan Baskin, Tama Dinur, Ehud Lebel, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
September 29, 2005
Uncomplicated outcome after anesthesia for pediatric patients with Gaucher disease
Alexandr Ioscovich, Alex Briskin, Aya Abrahamov, et al.
Blood Cells, Molecules & Diseases
|
July 24, 2014
Hypothesis: Concordance of Gaucher disease and large granular lymphocytic leukemia has biological plausibility
Rosa Ruchlemer, Hannah Maayan, Deborah Elstein, et al.
Journal of Perinatal Medicine
|
March 12, 2008
Retrospective audit of outcome of regional anesthesia for delivery in women with thrombocytopenia
Kyra Bernstein, Abigail Baer, Martine Pollack, et al.
Blood Cells, Molecules & Diseases
|
March 4, 2014
Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-year follow-up
Deborah Elstein, Andrew H Haims, David Zahrieh, et al.
Blood Cells, Molecules & Diseases
|
October 14, 2015
13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease
Deborah Elstein, Aya Abrahamov, Anat Oz, et al.
Nephron. Clinical Practice
|
July 20, 2010
Paraoxonase (PON1) gene polymorphisms in Fabry disease: correlation with renal disease
Tamar Shemesh, Catharina Whybra, Sandra Delgado-Sanchez, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 154) with videos related to
Sort By:
Page
of 16
Blood Cells, Molecules & Diseases
|
April 2, 2003
Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease
Bernard Rudensky, Esther Paz, Gheona Altarescu, et al.
American Journal of Clinical Pathology
|
June 15, 2013
Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement
Ehud Lebel, Deborah Elstein, Ariel Peleg, et al.
Journal of Osteoporosis
|
December 16, 2014
Bone mineral density in gravida: effect of pregnancies and breast-feeding in women of differing ages and parity
Ehud Lebel, Yuri Mishukov, Liana Babchenko, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
January 20, 2016
Comparison of Bone Mineral Density by Dual-Energy X-Ray Absorptiometry and Bone Strength by Speed-of-Sound Ultrasonography in Adults With Gaucher Disease
Eytan Baskin, Tama Dinur, Ehud Lebel, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
September 29, 2005
Uncomplicated outcome after anesthesia for pediatric patients with Gaucher disease
Alexandr Ioscovich, Alex Briskin, Aya Abrahamov, et al.
Blood Cells, Molecules & Diseases
|
July 24, 2014
Hypothesis: Concordance of Gaucher disease and large granular lymphocytic leukemia has biological plausibility
Rosa Ruchlemer, Hannah Maayan, Deborah Elstein, et al.
Journal of Perinatal Medicine
|
March 12, 2008
Retrospective audit of outcome of regional anesthesia for delivery in women with thrombocytopenia
Kyra Bernstein, Abigail Baer, Martine Pollack, et al.
Blood Cells, Molecules & Diseases
|
March 4, 2014
Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-year follow-up
Deborah Elstein, Andrew H Haims, David Zahrieh, et al.
Blood Cells, Molecules & Diseases
|
October 14, 2015
13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease
Deborah Elstein, Aya Abrahamov, Anat Oz, et al.
Nephron. Clinical Practice
|
July 20, 2010
Paraoxonase (PON1) gene polymorphisms in Fabry disease: correlation with renal disease
Tamar Shemesh, Catharina Whybra, Sandra Delgado-Sanchez, et al.
Page
of 16